Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.
Market Dynamics:
Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.
Key Features of the Study:
- This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
- It profiles key players in the global contraceptive market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market
Detailed Segmentation:
- Global Contraceptive Market, By Type
- Combination Contraceptives
- Monophasic pills
- Multiphasic pills
- Extended-cycle pills
- Hormonal Contraceptives
- Emergency Contraceptives
- Levonorgestrel-based
- Ulipristal acetate-based
- Global Contraceptive Market, By Route of Administration
- Oral
- Injectable
- Intrauterine
- Vaginal
- Others (Patches, etc.)
- Global Contraceptive Market, By Age Group
- Global Contraceptive Market, By Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
- Global Contraceptive Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Top Companies in the Global Contraceptive Market:
-
- Bayer AG
- Pfizer Inc.
- Teva Pharmaceutical Industries
- Merck & Co.
- Janssen Pharmaceutical Companies
- Allergan
- Piramal Enterprises
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals
- Mylan Pharmaceuticals
- Mithra Pharmaceuticals
- Gedeon Richter
- HLL Lifecare
- Cadila Healthcare
- Organon
- Other Prominent Players